ILX Share Price | Ilex Medical Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 1.70% and Operating profit at -16.19% over the last 5 years

With ROE of 6.37%, it has a Very Expensive valuation with a 1.10 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Retailing

Market cap

ILS 686 Million ()

P/E

17.00

Industry P/E

Dividend Yield

0.02%

Debt Equity

-0.34

Return on Equity

5.88%

Price to Book

1.02

Revenue and Profits:

Net Sales:

232 Million

(Quarterly Results - Dec 2024)

Net Profit:

8 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-16.05%

6 Months

-23.45%

1 Year

-5.06%

2 Years

-13.26%

3 Years

-49.84%

4 Years

-39.05%

5 Years

-40.86%

Ilex Medical Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.70%

EBIT Growth (5y)

-16.19%

EBIT to Interest (avg)

38.65

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

1.44

Tax Ratio

26.40%

Dividend Payout Ratio

35.00%

Pledged Shares

Institutional Holding

ROCE (avg)

38.34%

ROE (avg)

19.51%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.10

EV to EBIT

8.44

EV to EBITDA

4.58

EV to Capital Employed

1.16

EV to Sales

0.53

PEG Ratio

Dividend Yield

0.02%

ROCE (Latest)

13.76%

ROE (Latest)

6.37%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -3.37% vs 9.68% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -40.77% vs 136.36% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "232.00",
          "val2": "240.10",
          "chgp": "-3.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.20",
          "val2": "29.50",
          "chgp": "-7.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "1.20",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.70",
          "val2": "13.00",
          "chgp": "-40.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "60.70%",
          "val2": "71.70%",
          "chgp": "-1.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.46% vs 5.01% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -17.66% vs -45.64% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "920.40",
          "val2": "916.20",
          "chgp": "0.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "112.30",
          "val2": "124.80",
          "chgp": "-10.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "2.80",
          "chgp": "10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.70",
          "val2": "-3.50",
          "chgp": "-5.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.70",
          "val2": "55.50",
          "chgp": "-17.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.40%",
          "val2": "86.20%",
          "chgp": "-1.48%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]